Development and charecterization of PLGA-nanoparticles containing carvedilol

Journal of Pharmaceutical Sciences and Research

Volumn 1, Issue 3, 2009, Pages 123-128

  Jawahar, N ^a   Venkatesh, D Nagasamy ^a   Sureshkumar, R ^a   Senthil, V ^a   Ganesh, G N K ^a   Vinoth, P ^a   Sood, Sumeet ^a   Samanta, M K ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Biodistribution; Carvedilol; Nanoparticles; PLGA; Sustained release

Indexed keywords

CARVEDILOL; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG FORMULATION; DRUG SOLUBILITY; ENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RAT; SUSTAINED DRUG RELEASE;

EID: 77953425056     PISSN: None     EISSN: 09751459     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Stroe, A.F., Gheorghiade, M., Carvedilol: β-blockade and beyond.Rev cardiovasc Med.2004; 5(Suppl.1),18-27.
2. Shakwch.M et al. Poly(lactide-coglycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice. Eur.pharm.Biopharm.(2005),1-13.
3. Satturwar.P.M. et al. Biodegradation and invivo biocompatibility of rosin: a natural film forming polymer. AAPS PharmSci.Technol. (2003) 4.E.55.
4. Fulzelv S.V, et al. Study of the biodegradation and invivo biocompatibility of novel biomaterials.Eur.J.Pharm.Sci. 2003,20,53-61.
5. Fallal E.,et al. Biodegradable microparticles for the mucosal delivery of antibacterial and antigens.Int.J.Pharm. 2002, 242,15-24.
6. Dainge C., et al. Ideal uptake of Polyalkyl cyanoacrylate nanocapsules in the rat.J.Pharm.Pharmacol. 2000, 52, 1049-1056.
7. Florence A.T.,et al. The oral absorption of micro-nanoparticulates: neither exceptional nor unusual.Pharm.Res.1997,14,259-266.
8. Eldridge J.H.,et al. Controlled vaccine release in the gut associated lymphoid tissues.J.Control.Release.1990,11,205-214.
9. Jani P., et al. Nanoparticle uptake by the rat gastrointestinal mucosa.J.Pharm. Pharmacol.1990,42,821-826.
10. Shixiang Hou, et al. Dual agents loaded PLGA nanoparticles:Systematic study of particle size and drug entrapment efficiency.2008,69,445-453.
11. Rainer H. Muller, et al. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.Int.J. pharm.2008,354,227- 234.
12. Snjezana Stolnik, et al. PLGA nanoparticles prepared by Nanoprecipitation:Drug loading and release studies of water soluble drug.J.Control.Release.1999,57,171-185.
13. Farnaz Esmaeili, et al. PLGA Nanoparticles of different surface properties:Preparation and evaluation of their body distribution.Int.J.Pharm. (2008),349,249-255.
14. F.Yuvan, et al. Vascular permeabilty in human tumer genograft:molecular size depandance and cut-off size.Cancer Res.1995,55,3752-3756.